Transforming Tomorrow, Today
News & Updates from the National Brain Tumor Society
January 2015
Celebrating Progress in 2014 & Building Hope for a Successful 2015

The dawn of a New Year is a time for patient advocacy organizations like the National Brain Tumor Society to review progress made in the previous 12 months, and plan for how to create even greater impact for the brain tumor community in the coming year. As such, one of our traditions is our yearly update for the community on how all of your generosity and support is helping us move our mission for better treatments, and ultimately a cure for brain tumors, forward.

We've compiled a list of 10 of our proudest achievements of the year (in no particular order), which we were only able to accomplish with the many contributions made by our dedicated community, no matter how you took action with us in 2014. Read More

From the Blog
December 8, 2014
National Brain Tumor Society Names New Chief Executive Officer

National Brain Tumor Society set out on a national search to find an experienced executive capable of leading our organization through its next phase of growth. Sally M. Davis rose to the top during this exhaustive process. Sally is a successful senior-level fundraiser, as well as experienced executive and will be an asset for the National Brain Tumor Society during this important time in brain tumor research and development. Read More

December 19, 2014
Defeat GBM Research Collaborative Produces Important Discovery

Defeat GBM's Discovery Team believes they may have identified a mechanism by which glioblastoma multiforme cells become resistant to certain, initially promising treatments. They also believe there might be a way to reverse it. Read More

December 15, 2014
A Step Toward Identifying Risk Factors for Glioma

In 2007, the National Brain Tumor Society provided funding for an international project to search for more clues to one of the biggest mysteries of brain tumors - what causes them to develop. Recently, researchers from this project, dubbed the Gliogene Consortium, published preliminary results from their study, which suggest rare mutations in a gene called POT1 could be related to an increased risk for developing the brain tumor, oligodendroglioma. Read More

see all blog posts
Research in the News
Key Found for Suppression of Growth in Medulloblastomas

Scientists Map Out How Childhood Brain Tumors Relapse

Building on Opportunities in Cancer Research: National Cancer Institute's 2016 Annual Plan and Budget Proposal (PDF)

New Imaging Technique Helps Predict How Vision Recovers after Brain Tumor Removal

Novocure Announces FDA Approval of an IDE Supplement Allowing All Control Patients in its Phase III Trial in Newly Diagnosed GBM to Cross over to Receive Tumor Treating Fields (PDF)

Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study

Celldex Announces Completion of Enrollment in Phase 3 Study of Rindopepimut in Frontline Glioblastoma

Glioma Modified Atkins-based Diet in Patients With Glioblastoma (GLAD)
Upcoming Events
Delaware Brain Tumor Walk
Wilmington, DE - Saturday, April 25, 2015
Bay Area Brain Tumor Walk
San Francisco, CA - Saturday, May 2, 2015
Race for Hope DC
Washington, DC - Sunday, May 3, 2015
Event Spotlight
Charlotte, NC - Saturday, March 21, 2015
View All Events
Connect facebook twitter youtube flickr donate Forward to a Friend
National Brain Tumor Society is fiercely committed to finding better treatments, and ultimately a cure, for people living with a brain tumor today and anyone who will be diagnosed tomorrow. This means effecting change in the system at all levels.
title Was this e-mail forwarded to you?
Subscribe today. Forward to a friend.
55 Chapel Street, Suite 200, Newton, MA 02458
617 924 9997 | Contact us |
Update email preferences or unsubscribe
© National Brain Tumor Society - All Rights Reserved.